ArticleProstate cancer and prostatic diseases2016

The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism.

M Shiota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.